ERBB2 and breast cancer: To explore other methods of targeting autophagy we next turned to evaluate a protein kinase called HUNK, which we recently described as an activator of autophagy in HER2+ breast cancer cells, potentially contributing to trastuzumab and lapatinib resistance [16].